EMA 放行!AZ 旗下COVID-19 疫苗終獲歐盟全面上市許可| GeneOnline News 基因線上 GeneOnline - 04 Nov 2022 EMA 放行!AZ 旗下COVID-19 疫苗終獲歐盟全面上市許可| GeneOnline News ... More
EU regulator 'firmly convinced' that benefits of AstraZeneca vaccine outweigh the risks FRANCE 24 English - 16 Mar 2021 EU regulator 'firmly convinced' that benefits of AstraZeneca vaccine outweigh the risks ... More
EMA official says AstraZeneca shots have good risk-benefit profile for over 60s Reuters - 13 Jun 2021 EMA official says AstraZeneca shots have good risk-benefit profile for over 60s ... More
Blood Clots a Very Rare Side Effect of AstraZeneca Vaccine: EMA The Scientist Magazine - 08 Apr 2021 Blood Clots a Very Rare Side Effect of AstraZeneca Vaccine: EMA ... More
EU drug regulator: Unusual blood clot is 'very rare AstraZeneca side effect' BBC.com - 07 Apr 2021 EU drug regulator: Unusual blood clot is 'very rare AstraZeneca side effect' ... More
AstraZeneca: EMA says blood clots 'very rare' side effect DW (English) - 07 Apr 2021 AstraZeneca: EMA says blood clots 'very rare' side effect ... More
EMA awards double validation for Daiichi Sankyo and AstraZeneca’s cancer ADC Pharmaceutical Technology - 04 Mar 2024 EMA awards double validation for Daiichi Sankyo and AstraZeneca’s cancer ADC ... More
EMA has 'not yet reached conclusion' on AstraZeneca Medical Xpress - 06 Apr 2021 EMA has 'not yet reached conclusion' on AstraZeneca ... More
After EMA's opinion, vaccinations with AstraZeneca to resume tomorrow AIFA – Agenzia Italiana del Farmaco - 18 Mar 2021 After EMA's opinion, vaccinations with AstraZeneca to resume tomorrow ... More
EMA Launches Review of Clot Risk With AstraZeneca COVID Vaccine Medscape - 12 Mar 2021 EMA Launches Review of Clot Risk With AstraZeneca COVID Vaccine ... More
EMA Validates Parallel Applications for Datopotamab Deruxtecan in Two Types of Cancer PharmTech - 08 Mar 2024 EMA Validates Parallel Applications for Datopotamab Deruxtecan in Two Types of Cancer ... More
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 December 2022 ... European Union - 16 Dec 2022 Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 December 2022 ... ... More
European Medicines Agency: AstraZeneca Vaccine Safe - Benefits Outweigh Risks - Despite Possible Rare Events Health Policy Watch - 18 Mar 2021 European Medicines Agency: AstraZeneca Vaccine Safe - Benefits Outweigh Risks - Despite Possible Rare Events ... More
‘Benefits outweigh risk’: WHO says keep using AstraZeneca vaccine Al Jazeera English - 18 Mar 2021 ‘Benefits outweigh risk’: WHO says keep using AstraZeneca vaccine ... More
EMA recommends AstraZeneca's second Covid vaccine Evusheld The Brussels Times - 24 Mar 2022 EMA recommends AstraZeneca's second Covid vaccine Evusheld ... More
'Possible link' to blood clots but AstraZeneca benefits outweigh risks, EU regulator says FRANCE 24 English - 07 Apr 2021 'Possible link' to blood clots but AstraZeneca benefits outweigh risks, EU regulator says ... More
EU starts real-time review of AstraZeneca COVID-19 antibody cocktail Reuters - 14 Oct 2021 EU starts real-time review of AstraZeneca COVID-19 antibody cocktail ... More
EMA CHMP recommends AstraZeneca's Voydeya for PNH treatment Pharmaceutical Technology - 27 Feb 2024 EMA CHMP recommends AstraZeneca's Voydeya for PNH treatment ... More
EMA logs more clotting cases after AstraZeneca shot, death rate lower Reuters - 28 May 2021 EMA logs more clotting cases after AstraZeneca shot, death rate lower ... More